Rudwin Pharmaceuticals Private Limited
About Rudwin Pharmaceuticals Private Limited
Data last updated:
Rudwin Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It was incorporated on 19 June 2023.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U47721TS2023PTC174192.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Satyavathi Challa and Shiva Shankar Challa.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
Company details
Contact details
Rudwin Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana.
- Registered Address6 – 2 – 45/8; Ac Guards Advo, Lakdikapool, Hyderabad, Telangana, India – 500004
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Rudwin Pharmaceuticals Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Rudwin Pharmaceuticals Private Limited, buy the company report.
Board of directors of Rudwin Pharmaceuticals Private Limited
Rudwin Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satyavathi Challa | Director | 19 Jun 2023 | 3 Years 4 Months | Current |
| Shiva Shankar Challa | Director | 19 Jun 2023 | 3 Years 4 Months | Current |
| Uppuluri Anupama | Additional Director | 19 Mar 2024 | 2 Years 7 Months | Current |
| Sripurna Deepti Challa | Director | 04 Apr 2025 | 1 Years 6 Months | Current |
Legal cases
No court or tribunal cases involving Rudwin Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rudwin Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Rudwin Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Rudwin Pharmaceuticals Private Limited has 5 board changes on record since 2023: 4 appointments and 1 cessation. The latest: Sripurna Deepti Challa was appointed as Director on 04 Apr 2025.
Frequently asked questions
Rudwin Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. It was incorporated on 19 June 2023 (3+ years old) and is registered under CIN U47721TS2023PTC174192.
Rudwin Pharmaceuticals has 4 current directors:
- Satyavathi Challa - Director
- Shiva Shankar Challa - Director
- Uppuluri Anupama - Additional Director
- Sripurna Deepti Challa - Director
The latest financial statements of Rudwin Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Rudwin Pharmaceuticals is U47721TS2023PTC174192. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rudwin Pharmaceuticals was incorporated on 19 June 2023, making it 3+ years old. It is registered with the Registrar of Companies, Hyderabad.
Sripurna Deepti Challa was appointed as Director on 04 Apr 2025. Satyavathi Challa ceased to be Director on 15 Dec 2024. Uppuluri Anupama was appointed as Additional Director on 19 Mar 2024. Rudwin Pharmaceuticals has 5 board changes on record in total.
The registered office of Rudwin Pharmaceuticals is at 6 – 2 – 458; Ac Guards Advo, Lakdikapool, Hyderabad, Telangana, India – 500004.
Rudwin Pharmaceuticals can be reached at its registered office: 6 – 2 – 458; Ac Guards Advo, Lakdikapool, Hyderabad, Telangana, India – 500004.
Rudwin Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.